Department of Health and Human Services January 4, 2013 – Federal Register Recent Federal Regulation Documents

Prospective Grant of Exclusive License: The Development of Gene Expression Signatures of Neoplasm Responsiveness to mTOR and HDAC Inhibitor Combination Therapy
Document Number: 2012-31743
Type: Notice
Date: 2013-01-04
Agency: Department of Health and Human Services, National Institutes of Health
This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant to Empire Genomics LLC of an exclusive patent license to practice the inventions embodied in US Provisional Patent Application 61/558,402 entitled, ``Gene Expression Signatures of Neoplasm Responsiveness to Therapy'' [HHS Ref. E-013-2012/0-US-01], and all continuing applications and foreign counterparts. The patent rights in this invention have been assigned to the Government of the United States of America. The prospective exclusive license territory may be worldwide, and the field of use may be limited to:
Clinical Center; Notice of Meeting
Document Number: 2012-31741
Type: Notice
Date: 2013-01-04
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2012-31740
Type: Notice
Date: 2013-01-04
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2012-31739
Type: Notice
Date: 2013-01-04
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Document Number: 2012-31738
Type: Notice
Date: 2013-01-04
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Document Number: 2012-31737
Type: Notice
Date: 2013-01-04
Agency: Department of Health and Human Services, National Institutes of Health
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
Document Number: 2012-31692
Type: Notice
Date: 2013-01-04
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH)
Document Number: 2012-31689
Type: Notice
Date: 2013-01-04
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Subcommittee on Procedures Review, Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH)
Document Number: 2012-31685
Type: Notice
Date: 2013-01-04
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Medical Imaging Drugs Advisory Committee; Notice of Meeting
Document Number: 2012-31676
Type: Notice
Date: 2013-01-04
Agency: Food and Drug Administration, Department of Health and Human Services
Advisory Committee for Reproductive Health Drugs; Notice of Meeting
Document Number: 2012-31675
Type: Notice
Date: 2013-01-04
Agency: Food and Drug Administration, Department of Health and Human Services
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Document Number: 2012-31631
Type: Notice
Date: 2013-01-04
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2012-31630
Type: Notice
Date: 2013-01-04
Agency: Department of Health and Human Services, National Institutes of Health